REFERENCES
1. Alqahtani, M. S., Kazi, M., Alsenaidy, M. A., & Ahmad, M. Z. (2021). Advances in oral drug delivery. Frontiers in pharmacology, 12, 618411.
2. Alshawwa, S. Z., Kassem, A. A., Farid, R. M., Mostafa, S. K., & Labib, G. S. (2022). Nanocarrier drug delivery systems: characterization, limitations, future perspectives and implementation of artificial intelligence. Pharmaceutics, 14(4), 883.
3. Amidon, S., Brown, J. E., & Dave, V. S. (2015). Colon-targeted oral drug delivery systems: design trends and approaches. Aaps Pharmscitech, 16(4), 731-741.
4. Buya, A. B., Beloqui, A., Memvanga, P. B., & Préat, V. (2020). Self-nano-emulsifying drug-delivery systems: From the development to the current applications and challenges in oral drug delivery. Pharmaceutics, 12(12), 1194.
5. Ezike, T. C., Okpala, U. S., Onoja, U. L., Nwike, C. P., Ezeako, E. C., Okpara, O. J., ... & Nwanguma, B. C. (2023). Advances in drug delivery systems, challenges and future directions. Heliyon, 9(6).
6. Florek, J., Caillard, R., & Kleitz, F. (2017). Evaluation of mesoporous silica nanoparticles for oral drug delivery–current status and perspective of MSNs drug carriers. Nanoscale, 9(40), 15252-15277.
7. Homayun, B., Lin, X., & Choi, H. J. (2019). Challenges and recent progress in oral drug delivery systems for biopharmaceuticals. Pharmaceutics, 11(3), 129.
8. Ita, K. (2017). Dissolving microneedles for transdermal drug delivery: Advances and challenges. Biomedicine & Pharmacotherapy, 93, 1116-1127.
9. Jain, K. K. (2019). An overview of drug delivery systems. Drug delivery systems, 1-54.
10. Keller, L. A., Merkel, O., & Popp, A. (2022). Intranasal drug delivery: opportunities and toxicologic challenges during drug development. Drug delivery and translational research, 12(4), 735-757.
11. Liu, L., Yao, W., Rao, Y., Lu, X., & Gao, J. (2017). pH-Responsive carriers for oral drug delivery: challenges and opportunities of current platforms. Drug Delivery, 24(1), 569-581.
12. Lou, J., Duan, H., Qin, Q., Teng, Z., Gan, F., Zhou, X., & Zhou, X. (2023). Advances in oral drug delivery systems: challenges and opportunities. Pharmaceutics, 15(2), 484.
13. Mandal, U. K., Chatterjee, B., & Senjoti, F. G. (2016). Gastro-retentive drug delivery systems and their in vivo success: A recent update. Asian journal of pharmaceutical sciences, 11(5), 575-584.
14. Newman, S. P. (2017). Drug delivery to the lungs: challenges and opportunities. Therapeutic delivery, 8(8), 647-661.
15. Reinholz, J., Landfester, K., & Mailänder, V. (2018). The challenges of oral drug delivery via nanocarriers. Drug delivery, 25(1), 1694-1705.
16. Singh, N., Joshi, A., Toor, A. P., & Verma, G. (2017). Drug delivery: advancements and challenges. In Nanostructures for drug delivery (pp. 865-886). Elsevier.
17. Tewabe, A., Abate, A., Tamrie, M., Seyfu, A., & Abdela Siraj, E. (2021). Targeted drug delivery—from magic bullet to nanomedicine: principles, challenges, and future perspectives. Journal of Multidisciplinary Healthcare, 1711-1724.
18. Vargason, A. M., Anselmo, A. C., & Mitragotri, S. (2021). The evolution of commercial drug delivery technologies. Nature biomedical engineering, 5(9), 951-967.
19. Viswanathan, P., Muralidaran, Y., & Ragavan, G. (2017). Challenges in oral drug delivery: A nano-based strategy to overcome. In Nanostructures for oral medicine (pp. 173-201). Elsevier.
20. Wang, B., Hu, L., & Siahaan, T. J. (Eds.). (2016). Drug delivery: principles and applications. John Wiley & Sons.